New hope for kidney transplant patients battling BK virus
NCT ID NCT04542733
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 33 times
Summary
This study tests whether a combination of everolimus with reduced-dose tacrolimus works better than reduced-dose tacrolimus plus leflunomide for treating BK virus infection in kidney transplant recipients. BK virus can damage the new kidney, and standard treatment is lowering immune-suppressing drugs. The trial enrolls 50 adults with persistent BK virus in their blood and measures how well the virus clears over three months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Chulalongkorn Memorial Hospital
RECRUITINGBangkok, Bangkok, 10330, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.